Preston Ringo, DPM
Foot & Ankle Surgery · Damariscotta, MENPI 1164862405
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,174 of the $1,792 with a category attached, or 65.5%. 8 manufacturers reported payments, led by Treace Medical Concepts, Inc. at 57.3% of the total. Reporting peaked in 2023 at $1,189 and has fallen 63.6% since, to $433 in 2025.
Across 25 payments — averaging $71.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Treace Medical Concepts, Inc.$1K
- Paragon 28, Inc.$246
- Smith+Nephew$232
- Pfizer$110
- Organogenesis Inc.$65
- Bone Support Inc.$52
- plus $59 from 2 others
What the payments were for
- Travel & lodging$61935%
- Food & beverage$1,17465%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Treace Medical Concepts, Inc. | 9 | $1,027 |
| Paragon 28, Inc. | 2 | $246 |
| Smith+Nephew | 7 | $232 |
| Pfizer | 1 | $110 |
| Organogenesis Inc. | 3 | $65 |
| Bone Support Inc. | 1 | $52 |
| Amgen | 1 | $31 |
| Acumed LLC | 1 | $28 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Lapiplasty System$733
- TENOTAC 2.0$133
- TMC SPEEDMTP$116
- MTP$113
- ABRYSVO$110
How this compares
$1,792 in reported general payments places this provider in the 65th percentile of 33 foot & ankle surgery providers in Maine.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ketoconazole | 30 | $590 |
| Ammonium Lactate | 22 | $333 |
| Cefadroxil | 27 | $173 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 16 | $94 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Damariscotta
- Barry WhiteYarmouth$330K
- Ashley MychakRockport$84K
- Jules BodoPortland$18K
- James FullwoodPittsfield$17K
- Todd ObrienOld Town$4K
- Kenneth FlaniganPortland$3K
- Thanh Thao NguyenScarborough$3K
- Rihua ChenBiddeford$3K
- Zachary BlakemanFarmington$3K
- Samuel HallRockport$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.